Key Market Indicators
The United States ranked number 1 in 2021, followed by France, Italy, and China respectively taking numbers 2, 3 and 4 in this ranking. Indian insulin exports are projected to reach around $176 million by 2026, up from $152 million in 2021. This growth is estimated at a CAGR of 2.6% year-on-year. Since 1993, Indian supplies have grown 6.8% year-on-year. In 2021, the United States led the ranking with $152 million, followed by France, Italy, and China respectively. Imports of Indian insulin are expected to reach $277 million in 2026, up from $235 million in 2021. This growth is estimated at a CAGR of 2.8% year-on-year. Since 1993, Indian demand has increased 3.5% year-on-year. In 2021, the United States topped the ranking, followed by France, Italy, and China in second, third, and fourth place respectively.
